Regulatory capture and patient manipulation in the MAHA crosshairs.
The Trump administration is mulling policies to make it more difficult and costly for pharmaceutical companies to promote prescription drugs directly to consumers. Big Pharma spends billions on advertising to promote sales, yet not all of its products are necessary or even safe, contributing to the overmedication of many Americans. Concerns about the industry’s excessive influence on news reports, enabled by their mighty purse strings, further motivate efforts to curb the incessant bombardment of ads for pills aimed at Americans.
Big Advertising by Big Pharma
Large pharmaceutical companies seek to sell new drugs ahead of generic competition and to persuade potential patients to ask their doctors to prescribe them. One study, led by the Johns Hopkins Bloomberg…




